AI, Competitor News, Fundraising/IPO

Takeda Canada Innovation Challenge Awarded to Pentavere to Accelerate Rare Disease Diagnosis and Care Using New AI Technology

Posted on

FOR CANADIAN AUDIENCES ONLY Toronto-based Pentavere will collaborate with Takeda Canada and receive dedicated funding for new proof-of-concept AI project focused on Rare Disease care Innovation Challenge was launched to find new partners and identify breakthrough ideas to support advancements in Rare Disease diagnoses through AI technology Investment will support Rare Disease…

Industry News, Oncology, RWE Study

Review of MM Treatment Landscape Compares Clinical Trials With Real-World Results

Posted on

July 2, 2022 Rose McNulty Real-world patients often differ from those eligible for clinical trials, and comparing results in both populations is a key step in fine-tuning treatment strategies for multiple myeloma. Populations in clinical trials and real-world patients are often different, and multiple myeloma (MM) trials are no exception. Considering the…

Europe, Government/Regulatory, Industry News, International, Oncology

Major EU Research Project Targets Personalized Medicine, Unlocking Of Health Data

Posted on

Executive Summary Neurodegenerative and cardiovascular diseases, along with cancer and early feasibility studies, are among the topics to be addressed by consortia interested in taking part in the EU’s latest research partnership.Source: Shutterstock/Vladimir SukhachevTHE EU’S IHI IS SEEKING NEW APPROACHES TO INNOVATIVE TREATMENTS Europe’s public-private partnership, the Innovative Health Initiative,…

Academic, Fundraising/IPO, Partner and Collaborator News

UC Davis receives $1.7 million for digital health equity

Posted on

Rep. Doris Matsui announces federal funding for the creation of a regional digital public health platform (SACRAMENTO) On Monday, Rep. Doris Matsui (CA-06) announced $1.7 million of federal funding for UC Davis Health’s Digital Health Equity Program at a press conference on the Sacramento campus. The federal funding, which Matsui championed as…

Competitor News

Closing the Gaps in Health Equity — A Call to Action for Commercial Teams

Posted on

by Vivian DeWoskin, VP, Life Sciences Strategy June 30, 2022 Topics: Perspectives, Commercial, Race and Ethnicity, Health Equity While the last two years of pandemic-driven disruption have spotlighted race-based disparities in healthcare, the problem is not a new one. Populations of color have been persistently under-represented and have consistently experienced worse outcomes and higher disease risk for…

Academic, Collaborations, Competitor News, Data Partnership, Oncology

Analysis of Tumor Mutation, Treatment Data Across Cancers Points to Predictive Biomarkers

Posted on

Jun 30, 2022 | staff reporter NEW YORK – A pan-cancer analysis involving tens of thousands of patients has spelled out new and known relationships between tumor mutations, survival outcomes, and responses to a range of cancer treatment strategies. “This work demonstrates how computational analysis of large real-world data can facilitate precision…

Collaborations, Data Partnership, Industry News, Oncology

Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data

Posted on

Abstract Quantifying the effectiveness of different cancer therapies in patients with specific tumor mutations is critical for improving patient outcomes and advancing precision medicine. Here we perform a large-scale computational analysis of 40,903 US patients with cancer who have detailed mutation profiles, treatment sequences and outcomes derived from electronic health…

Europe, Government/Regulatory, Industry News, International

England: HTA Body NICE Makes Big RWE Push

Posted on

Executive Summary England’s health technology appraisal institute, NICE, has published its real-world evidence framework.NICE LAUNCHES RWE FRAMEWORK With its newly published real-world evidence (RWE) framework, NICE, England’s health technology appraisal (HTA) institute, is making “a real push into real-world data in a big way,” Sam Roberts, NICE’s chief executive, said…